相关实验视频
Updated: Jul 13, 2025

03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
5.5K
评估深度Q学习算法,以控制血糖在1型糖尿病中
Miguel Tejedor1, Sigurd Nordtveit Hjerde2, Jonas Nordhaug Myhre3
1Norwegian Centre for E-Health Research, P.O. Box 35, N-9038 Tromsø, Norway.
Diagnostics (Basel, Switzerland)
|October 14, 2023
概括
深度Q学习算法在1型糖尿病管理中显示出自动化胰岛素输送的前景. 这些无模型的方法可以个性化控制葡萄糖,可能会优于传统的治疗方法,以更好地调节血糖.
科学领域:
- 人工智能的人工智能
- 生物医学工程 生物医学工程
- 内分泌学 在内分泌学.
背景情况:
- 1型糖尿病需要持续的胰岛素管理来维持血糖水平.
- 强化学习 (RL) 为自动化血糖控制提供了一个潜在的解决方案.
- 深度Q学习 (DQL) 算法正在探索个性化糖尿病护理.
研究的目的:
- 评估DQL算法用于1型糖尿病的自动胰岛素剂量.
- 评估没有模型的RL方法的个性化能力.
- 在模拟环境中将DQL性能与标准处理进行比较.
主要方法:
- 模拟的1型糖尿病患者使用Hovorka模型.
- 在模拟中纳入食变化和碳水化合物计数错误.
- 测试和比较几个DQL算法扩展.
主要成果:
- DQL算法证明了有效的血糖调节.
- 一些DQL扩展的性能优于标准基线治疗.
- 没有模型的方法在没有先前的患者特异性数据的情况下显示可行性.
结论:
- 深度Q学习为自动化和个性化胰岛素治疗提供了一个有前途的途径.
- 基于RL的系统有可能改善1型糖尿病患者的血糖控制.
- 对糖尿病管理的DQL进行进一步的研究是有必要的.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes: Management and Pharmacotherapy
290
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
290
Glucagon-like Receptor Agonists
334
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
334
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Hormones Regulating Blood Glucose
3.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K

